Plans unveiled for new life sciences investment group
Cancer Research UK is linking with the Wellcome Trust and investment groups Syncona and BACIT to create a new company, to be listed on the London Stock Exchange with assets of up to £1 billion, that will stream funds into life sciences.
Read More
